Managing atrial fibrillation in the global community: The European perspective

Area of Science:

• Cardiology
• Geriatrics
• Public Health

Background:

• Atrial fibrillation (AF) is a prevalent global health issue with significant personal, economic, and social impacts.
• Increasing prevalence due to aging populations necessitates effective chronic management strategies.
• AF is a major cause of morbidity, primarily due to stroke, highlighting the need for robust prevention.

Purpose of the Study:

• To provide a concise overview of current Atrial fibrillation management strategies.
• To highlight advancements in risk assessment, pharmacological interventions, and procedural treatments for AF.
• To guide clinicians in optimizing chronic AF care.

Main Methods:

• Review of current literature and clinical guidelines on Atrial fibrillation management.
• Analysis of advancements in stroke risk prediction models and pharmacological therapies.
• Examination of contemporary electrophysiology techniques for AF treatment.

Main Results:

• Stroke risk assessment in AF is enhanced by computerized databases and validated prediction models.
• A growing array of antithrombotic and rhythm-controlling medications are available for AF.
• Electrophysiology interventions offer targeted treatment options for the underlying pathophysiology of AF.

Conclusions:

• Successful management of Atrial fibrillation requires a multifaceted approach integrating risk stratification, pharmacotherapy, and advanced electrophysiology.
• Ongoing updates in guidelines and therapeutic options are crucial for minimizing AF-related morbidity.
• Comprehensive management strategies are essential for addressing the growing burden of AF in aging populations.